Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asrani

Showing results (401-410 of 524) with videos related to

Pageof 53
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 16, 2016
Predicting renal recovery after liver transplant with severe pretransplant subacute kidney injury: The impact of warm ischemia timeHeather L Laskey, Nathan Schomaker, Kenneth W Hung, et al.
Gastroenterology|September 5, 2021
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern EraW Ray Kim, Ajitha Mannalithara, Julie K Heimbach, et al.
Transplantation Direct|October 8, 2025
The Landscape of In Situ and Ex Situ Machine Perfusion Utilization for Liver Grafts From Noncardiac Donation After Circulatory Death Donors in the Early era of Machine Perfusion in the United StatesAnji Wall, Jinyu Du, Matthew Snoddy, et al.
The American Journal of Gastroenterology|May 17, 2021
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016Christopher Ma, Alexander S Qian, Nghia H Nguyen, et al.
Journal of the American College of Radiology : JACR|November 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Chronic Liver Disease, Jeanne M Horowitz, Ihab R Kamel, et al.
Hepatology (Baltimore, Md.)|September 17, 2019
MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting ListSumeet K Asrani, Linda W Jennings, W R Kim, et al.
The International Journal of Biochemistry & Cell Biology|November 8, 2021
Clinical features and mechanistic insights into drug repurposing for combating COVID-19Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, et al.
Clinical Transplantation|September 21, 2021
Longitudinal profiling of plasma and urine metabolites during liver regeneration in living liver donorsTeodoro Bottiglieri, Xuan Wang, Erland Arning, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2014
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trialS K Asrani, R H Wiesner, J F Trotter, et al.
Hepatology (Baltimore, Md.)|December 23, 2017
Patient-reported outcomes in cirrhosis: A scoping review of the literatureElliot B Tapper, Fasiha Kanwal, Sumeet K Asrani, et al.
Pageof 53

Showing results (401-410 of 524) with videos related to

Sort By:
Pageof 53
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 16, 2016
Predicting renal recovery after liver transplant with severe pretransplant subacute kidney injury: The impact of warm ischemia timeHeather L Laskey, Nathan Schomaker, Kenneth W Hung, et al.
Gastroenterology|September 5, 2021
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern EraW Ray Kim, Ajitha Mannalithara, Julie K Heimbach, et al.
Transplantation Direct|October 8, 2025
The Landscape of In Situ and Ex Situ Machine Perfusion Utilization for Liver Grafts From Noncardiac Donation After Circulatory Death Donors in the Early era of Machine Perfusion in the United StatesAnji Wall, Jinyu Du, Matthew Snoddy, et al.
The American Journal of Gastroenterology|May 17, 2021
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016Christopher Ma, Alexander S Qian, Nghia H Nguyen, et al.
Journal of the American College of Radiology : JACR|November 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Chronic Liver Disease, Jeanne M Horowitz, Ihab R Kamel, et al.
Hepatology (Baltimore, Md.)|September 17, 2019
MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting ListSumeet K Asrani, Linda W Jennings, W R Kim, et al.
The International Journal of Biochemistry & Cell Biology|November 8, 2021
Clinical features and mechanistic insights into drug repurposing for combating COVID-19Purva Asrani, Keshav Tiwari, Mathew Suji Eapen, et al.
Clinical Transplantation|September 21, 2021
Longitudinal profiling of plasma and urine metabolites during liver regeneration in living liver donorsTeodoro Bottiglieri, Xuan Wang, Erland Arning, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2014
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trialS K Asrani, R H Wiesner, J F Trotter, et al.
Hepatology (Baltimore, Md.)|December 23, 2017
Patient-reported outcomes in cirrhosis: A scoping review of the literatureElliot B Tapper, Fasiha Kanwal, Sumeet K Asrani, et al.
Pageof 53